Download now: life sciences - whitepaper: building an investable ip portfolio
​

UKIPO report of IP trends for UK Higher Education Institutions highlights life sciences innovation

No items found.
​
April 30, 2020
Additional information
Chevron icon
Info
Tags
Life
Table of contents
Chevron icon
Table of contents
  • Toc Heading
  • Toc Heading

On 29 April 2020, the UKIPO published an overview report of IP trends for UK Higher Education Institutions (HEIs) and their spin-out businesses, between 1999 and 2018. We focus on some of the main takeaways and trends from this overview for the life sciences sector below.

The report highlights the value that UK universities place on life sciences innovation, as reflected by the impressive percentage of patent publications in the fields of Biotechnology and Pharmaceuticals. Indeed, 47 % of UK HEI patent publications are in the Chemistry sector (over 50% of which used pharmaceuticals and biotechnology IPC technology fields), compared to 21% of all patent publications globally.

Notably, there was a rise in the level of international collaboration between UK HEIs and entities abroad, particularly in the US. This trend demonstrates both the aim of universities to more effectively exploit their IP commercially and the importance of collaboration for the transfer of technology.

Life sciences powerhouses Imperial College London, UCL and Oxford University were among those institutions showing not only the largest output of published applications, but also the greatest proportional increase in activity. Furthermore, of the top 10 spin-out businesses, according to the number of applications, six of these have a biotechnological focus, including DNA sequencing products, biotherapeutics and drug discovery.

The importance of innovation within the life sciences sector to UK universities, and the UK as a whole, is clear from this report. As we move into the era of personalised medicine and with Artificial Intelligence and machine learning becoming increasingly significant in healthcare innovation, it will be interesting to see whether UK HEIs continue to lead in this new era and whether more and more computer technology related patent filings over the next 20 years will be important to the healthcare sector.

Recent Case Reports

See all Case Reports

Court of Appeal focuses on the technical effect to determine added matter
30 September 2026
The Court of Appeal provided guidance on their approach to assessing added subject matter, highlighting that the technical effect underlying the invention and how the claimed and unclaimed features contribute thereto is central to the analysis.
​
Court of Appeal affirms interpretation of product-by-process features in claims, and clarifies applicable law pre-June 2023
29 September 2026
The Court of Appeal confirmed that product-by-process features in a product claim limit the claim only where the specified process imparts characteristics that can be achieved solely by that process. It also clarified the law applicable to acts occurring before 1 June 2023, holding that UPC law may apply to ongoing infringement for injunctive relief, whereas damages for acts completed before that date are governed by national law, and that claims for provisional protection remain governed by national law.
​
Appeal reveals tricky deadlines for orders contained in decisions
29 September 2026
The Court of Appeal held that where a “privileged order” under Rule 220(1)(c), such as an order relating to the production of evidence under Article 59 UPCA and Rule 190 RoP, is contained within a decision on the merits, a 15 day appeal deadline for that order applies, separate from the substantive appeal deadline. Appeals challenging such orders after that deadline are inadmissible, and parties cannot circumvent the appeal rules by re-filing substantially the same request in the appeal proceedings.
​